These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24778992)

  • 21. [Clonal hematopoiesis in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Makishima H
    Rinsho Ketsueki; 2022; 63(9):1042-1045. PubMed ID: 36198527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelodysplastic syndromes: the pediatric point of view.
    Locatelli F; Zecca M; Pession A; Maserati E; De Stefano P; Severi F
    Haematologica; 1995; 80(3):268-79. PubMed ID: 7672722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones.
    Maciejewski JP; O'Keefe C; Gondek L; Tiu R
    Folia Histochem Cytobiol; 2007; 45(1):5-14. PubMed ID: 17378239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxysmal nocturnal hemoglobinuria as a marker for clonal myelopathy.
    Graham DL; Gastineau DA
    Am J Med; 1992 Dec; 93(6):671-4. PubMed ID: 1466364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease.
    Ogura Y; Mimura I
    Front Cell Dev Biol; 2023; 11():1281850. PubMed ID: 37928907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders.
    Maio M; Pinto A; Carbone A; Zagonel V; Gloghini A; Marotta G; Cirillo D; Colombatti A; Ferrara F; Del Vecchio L
    Blood; 1990 Aug; 76(4):783-90. PubMed ID: 1974471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic mastocytosis with myeloid sarcoma and B-CLL: molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature.
    Decruyenaere P; Mazure D; Moors I; Van Dorpe J; Van der Linden M; Denys B; Hofmans M; Offner F
    Acta Clin Belg; 2023 Feb; 78(1):58-66. PubMed ID: 35098906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Review of Systemic Hematological Manifestations and Stent Thrombosis.
    Biggart R; Davies C; Joshi N
    Cardiol Rev; 2023 Feb; ():. PubMed ID: 36825903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical relevance of immunotyping of oncologic and hematologic diseases].
    Diehl V; Pfreundschuh M
    Onkologie; 1987 Jun; 10(3):114-20. PubMed ID: 3306529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
    Zhang LJ; Shin ES; Yu ZX; Li SB
    Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors.
    Ungerstedt JS
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epigenetic dysregulation in myelodysplastic syndromes].
    Sashida G
    Rinsho Ketsueki; 2017; 58(10):1809-1817. PubMed ID: 28978819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
    Fujino T
    Rinsho Ketsueki; 2022; 63(6):561-572. PubMed ID: 35831189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review.
    Prieto-Torres L; Requena L; Rodríguez-Pinilla SM
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of the Role of Runt-Related Transcription Factor 1 (RUNX1) in the Pathogenesis of Hematological Malignancies in Patients With Inherited Bone Marrow Failure Syndromes.
    Illango J; Sreekantan Nair A; Gor R; Wijeratne Fernando R; Malik M; Siddiqui NA; Hamid P
    Cureus; 2022 May; 14(5):e25372. PubMed ID: 35765406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.
    Kuendgen A; Kasprzak A; Germing U
    Front Oncol; 2021; 11():778741. PubMed ID: 34869027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunodeficiency-associated lymphoproliferative disorders.
    Knowles DM
    Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil Function in Hematological Neoplasia.
    Matzner Y
    Leuk Lymphoma; 1991; 4(1):9-15. PubMed ID: 27462713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.